Alejandra Perez

Associate Professor of Clinical and Director, Braman Family Breast Cancer Institute at Plantation

  • 2374 Citations
19962016
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alejandra Perez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
exemestane Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Hormones Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Safety Medicine & Life Sciences
Scutellaria Medicine & Life Sciences
Diamond-Blackfan Anemia Medicine & Life Sciences
Idarubicin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2016

  • 2374 Citations
  • 14 Article
87 Citations (Scopus)

Correlative analysis of genetic alterations and everolimus benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Results from BOLERO-2

Hortobagyi, G. N., Chen, D., Piccart, M., Rugo, H. S., Burris, H. A., Pritchard, K. I., Campone, M., Noguchi, S., Perez, A., Deleu, I., Shtivelband, M., Masuda, N., Dakhil, S., Anderson, I., Robinson, D. M., He, W., Garg, A., McDonald, E. R., Bitter, H., Huang, A. & 5 others, Taran, T., Bachelot, T., Lebrun, F., Lebwohl, D. & Baselga, J., Feb 10 2016, In : Journal of Clinical Oncology. 34, 5, p. 419-426 8 p.

Research output: Contribution to journalArticle

Hormones
Breast Neoplasms
Chromosomal Instability
exemestane
Disease-Free Survival
259 Citations (Scopus)

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†

Piccart, M., Hortobagyi, G. N., Campone, M., Pritchard, K. I., Lebrun, F., Ito, Y., Noguchi, S., Perez, A., Rugo, H. S., Deleu, I., Burris, H. A., Provencher, L., Neven, P., Gnant, M., Shtivelband, M., Wu, C., Fan, J., Feng, W., Taran, T. & Baselga, J., Dec 1 2014, In : Annals of Oncology. 25, 12, p. 2357-2362 6 p.

Research output: Contribution to journalArticle

exemestane
Hormones
Breast Neoplasms
Survival
Disease-Free Survival
86 Citations (Scopus)

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2

Rugo, H. S., Pritchard, K. I., Gnant, M., Noguchi, S., Piccart, M., Hortobagyi, G., Baselga, J., Perez, A., Geberth, M., Csoszi, T., Chouinard, E., Srimuninnimit, V., Puttawibul, P., Eakle, J., Feng, W., Bauly, H., El-hashimy, M., Taran, T. & Burris, H. A., 2014, In : Annals of Oncology. 25, 4, p. 808-815 8 p., mdu009.

Research output: Contribution to journalArticle

exemestane
Hormones
Breast Neoplasms
Incidence
Safety
13 Citations (Scopus)

Anopen-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer

Esteva, F. J., Franco, S. X., Hagan, M. K., Brewster, A. M., Somer, R. A., Williams, W., Florance, A. M., Turner, S., Stein, S. & Perez, A., 2013, In : Oncologist. 18, 6, p. 661-666 6 p.

Research output: Contribution to journalArticle

Paclitaxel
Breast Neoplasms
Safety
Diarrhea
Incidence
1684 Citations (Scopus)

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., Beck, J. T., Ito, Y., Yardley, D., Deleu, I., Perez, A., Bachelot, T., Vittori, L., Xu, Z., Mukhopadhyay, P., Lebwohl, D. & 1 others, Hortobagyi, G. N., Feb 9 2012, In : New England Journal of Medicine. 366, 6, p. 520-529 10 p.

Research output: Contribution to journalArticle

exemestane
Hormones
Breast Neoplasms
letrozole
Sirolimus